Tag: entrepreneurs
-
Start-Up’s Air Quality Technology to Clean City Areas
10 November 2015. A start-up company is licensing research from University of Copenhagen in Denmark to develop a technology for removing air pollution from city neighborhoods. The air cleaning technology, known as gas phase advanced oxidation, is a product of the atmospheric chemistry lab led by Matthew Johnson, who also serves as chief scientist for…
-
Biotech Targets “Undruggable” Cancer Gene
9 November 2015. A biotechnology company says it plans to focus its technology platform on a cancer-causing gene previously considered beyond the direct reach of today’s cancer drugs. Warp Drive Bio, in Cambridge, Massachusetts told an American Association of Cancer Research meeting in Boston on Saturday the company plans to target the Ras oncogene, a…
-
Compound Found to Reverse Lens Clouding in Cataracts
6 November 2015. A biochemical and medical research team discovered a steroid that when given as eye drops to mice, reverses the accumulation of protein formations in cataracts. Researchers from the labs of protein chemistry professor Jason Gestwicki at University of Michigan and ophthalmology professor Usha Andley at Washington University in St. Louis published their…
-
Artificial Kidney Implant Gains $6 Million Funding
3 November 2015. A collaboration of engineering and medical researchers is developing an implantable artificial kidney to reduce the need for dialysis in people with kidney failure awaiting a transplant. The four-year project combining teams from University of California in San Francisco with Vanderbilt University in Nashville, is funded by a $6 million grant from…
-
Computer Model Devised to Predict Drug Side Effects
2 November 2015. A systems biology lab developed a prototype computer model that can test for potential side effects of drugs from an individual’s blood sample. The team led by bioengineering professor Bernhard Palsson at University of California in San Diego published its proof-of-concept results last week in the journal Cell Systems. Palsson and first…
-
Biotech, Accelerator to Partner on Glaucoma Treatment
30 October 2015. A new eye-drop treatment for the underlying causes of glaucoma is being developed in a collaboration between a biotechnology enterprise spun-off from Northwestern University and a company that acquires biomedical research assets. Financial aspects of the deal between Mannin Research Inc. in Toronto, Ontario, Canada and Q BioMed Inc. in New York…
-
Univ Lab, Spin-Off Developing Drug from Turmeric
28 October 2015. A university biochemistry lab and spin-off enterprise developing drugs from plants are collaborating on a process for extracting a key ingredient for an anti-inflammatory compound from the common spice turmeric. The project, bringing together the lab of biochemistry professor David Gang at Washington State University and Botanisol LLC in Scottsdale, Arizona, is…
-
Gene Editing Licensed for Inherited Disease Treatments
26 October 2015. A Boston biotechnology company is licensing gene-editing technologies from a nearby start-up to design treatments for cystic fibrosis and inherited blood disorders, including sickle cell disease. Vertex Pharmaceuticals, in Boston, received rights to techniques known as CRISPR-Cas9 in a deal that could bring CRISPR Therapeutics, founded in April 2014, as much as…
-
Two Current Drugs Shown Also to Promote Hair Growth
23 October 2015. Research originally designed to study hair loss from an autoimmune disorder, uncovered two drugs now on the market that in lab tests show they may also regrow hair. Findings of the study led by molecular dermatology professor Angela Christiano at Columbia University in New York appear in today’s issue of the journal…
-
Immunotherapy Start-Up Gains $102M in Venture Funds
20 October 2015. A new enterprise founded by researchers in the U.S. and Europe that aims to provide personalized cancer therapies harnessing the immune system raised $102 million in its first round of venture financing. The company Gritstone Oncology — in San Francisco and Cambridge, Massachusetts — says it plans to focus initially on developing…